REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P953. A total of 5 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,196,000 | -43.4% | 120 | -29.8% | 0.04% | -43.0% |
Q4 2020 | $2,114,000 | +267.7% | 171 | +189.8% | 0.08% | +125.7% |
Q3 2020 | $575,000 | -64.9% | 59 | -43.8% | 0.04% | -68.8% |
Q2 2020 | $1,638,000 | -3.8% | 105 | -11.0% | 0.11% | -20.6% |
Q1 2020 | $1,703,000 | +259.3% | 118 | +100.0% | 0.14% | +227.9% |
Q3 2019 | $474,000 | -14.9% | 59 | 0.0% | 0.04% | -15.7% |
Q2 2019 | $557,000 | +10.5% | 59 | 0.0% | 0.05% | +4.1% |
Q1 2019 | $504,000 | – | 59 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 60,000 | $5,845,000 | 0.43% |
BOOTHBAY FUND MANAGEMENT, LLC | 59 | $575,000 | 0.04% |
GROUP ONE TRADING, L.P. | 3,600 | $351,000 | 0.00% |
SIMPLEX TRADING, LLC | 60 | $584,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |